临床放射性核素治疗剂量测定：对“神圣格雷”的探寻。 - Suppr

Suppr

超能文献

Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".

作者信息

Flux Glenn, Bardies Manuel, Chiesa Carlo, Monsieurs Myriam, Savolainen Sauli, Strand Sven-Erik, Lassmann Michael

出版信息

Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1699-700. doi: 10.1007/s00259-007-0471-9.

DOI:10.1007/s00259-007-0471-9

PMID:17565497

Abstract

摘要

相似文献

Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".

Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1699-700. doi: 10.1007/s00259-007-0471-9.

Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".

Eur J Nucl Med Mol Imaging. 2007 May;34(5):772-786. doi: 10.1007/s00259-006-0338-5.

Dosimetry in nuclear medicine therapy: what are the specifics in image quantification for dosimetry?

Q J Nucl Med Mol Imaging. 2011 Feb;55(1):5-20.

[Nuclear medicine in oncotherapy].

Magy Onkol. 2015 Sep;59(3):193-7. Epub 2015 Apr 11.

Iodine-131 and Iodine-131-Meta-iodobenzylguanidine Dosimetry in Cancer Therapy.

Semin Nucl Med. 2022 Mar;52(2):167-177. doi: 10.1053/j.semnuclmed.2021.11.002. Epub 2021 Dec 24.

Radionuclide therapy beyond radioiodine.

Wien Med Wochenschr. 2012 Oct;162(19-20):430-9. doi: 10.1007/s10354-012-0128-6. Epub 2012 Jul 20.

[Guideline draft of appropriate use of 131I-MIBG for internal radiotherapy of neuroendocrine tumors].

Kaku Igaku. 2008 Feb;45(1):suppl 1-40.

Clinical applications of dosimetry for mIBG therapy.

Q J Nucl Med Mol Imaging. 2011 Apr;55(2):116-25.

Optimization of molecular radiotherapy with [131I]-meta Iodobenzylguanidine for high-risk neuroblastoma.

Q J Nucl Med Mol Imaging. 2013 Mar;57(1):66-78.

Intraarterial 131I-MIBG therapy of neuroendocrine tumors with liver metastases.

Nuklearmedizin. 2010;49(1):N2-3.

引用本文的文献

Comparison of Accuracy in Calculation of Absorbed Dose to the Kidneys Following Radioligand Therapy with Lu-DKFZ-PSMA-617 by Two Different Background Correction Methods.

Indian J Nucl Med. 2022 Apr-Jun;37(2):121-125. doi: 10.4103/ijnm.ijnm_134_21. Epub 2022 Jul 8.

Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer.

Diagnostics (Basel). 2022 Jul 21;12(7):1763. doi: 10.3390/diagnostics12071763.

Toward Individualized Voxel-Level Dosimetry for Radiopharmaceutical Therapy.

Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):902-904. doi: 10.1016/j.ijrobp.2020.08.026.

The physics of radioembolization.

EJNMMI Phys. 2018 Nov 2;5(1):22. doi: 10.1186/s40658-018-0221-z.

Comparison of Accuracy in Calculation of Absorbed Dose to Patients Following Bone Scan with (99m)Tc-Marked Diphosphonates by Two Different Background Correction Methods.

J Med Signals Sens. 2016 Jan-Mar;6(1):33-8.

The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy.

Eur J Nucl Med Mol Imaging. 2014 Oct;41(10):1976-88. doi: 10.1007/s00259-014-2824-5. Epub 2014 Jun 11.

Study of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: comparison between dose kernel convolution and direct Monte Carlo methods.

J Nucl Med. 2013 Feb;54(2):236-43. doi: 10.2967/jnumed.112.105825. Epub 2012 Dec 18.

Experimental facts supporting a red marrow uptake due to radiometal transchelation in 90Y-DOTATOC therapy and relationship to the decrease of platelet counts.

Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1270-80. doi: 10.1007/s00259-011-1744-x. Epub 2011 Feb 12.

Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres.

Eur J Nucl Med Mol Imaging. 2010 Aug;37(9):1654-62. doi: 10.1007/s00259-010-1470-9. Epub 2010 Apr 27.

Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma.

Eur J Nucl Med Mol Imaging. 2010 Apr;37(4):821-8. doi: 10.1007/s00259-010-1398-0.

本文引用的文献

Radioactive iodine therapy; effect on functioning metastases of adenocarcinoma of the thyroid.

J Am Med Assoc. 1946 Dec 7;132(14):838-47. doi: 10.1001/jama.1946.02870490016004.

Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".

Eur J Nucl Med Mol Imaging. 2007 May;34(5):772-786. doi: 10.1007/s00259-006-0338-5.

Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.

J Nucl Med. 2006 Apr;47(4):648-54.

Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.

J Nucl Med. 2004 Aug;45(8):1366-72.

Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG.

J Nucl Med. 2001 Nov;42(11):1713-21.

Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.

Crit Rev Oncol Hematol. 2001 Jul-Aug;39(1-2):181-94. doi: 10.1016/s1040-8428(01)00107-x.

The European Directive on health protection of individuals against the dangers of ionising radiation in relation to medical exposures (97/43/EURATOM).

J Radiol Prot. 1998 Jun;18(2):133-7. doi: 10.1088/0952-4746/18/2/009.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验